Related Experiment Video
Updated: Mar 27, 2026

Feeding of Ticks on Animals for Transmission and Xenodiagnosis in Lyme Disease Research
Published on: August 31, 2013
Tularaemia: clinical aspects in Europe
Max Maurin1, Miklós Gyuranecz2
1Centre National de Référence des Francisella, Département des Agents Infectieux, Institut de Biologie et Pathologie, CHU de Grenoble, Grenoble, cedex 9, France; Université Grenoble Alpes and Centre National de la Recherche Scientifique, Laboratoire Adaptation et Pathogénie des Microorganismes, IMR 5163, Grenoble, France.
Tularaemia, a zoonotic disease caused by Francisella tularensis, presents distinct characteristics in Europe. This review highlights the variability in transmission, clinical features, and public health impact across European countries.
Area of Science:
- Infectious Diseases
- Bacteriology
- Epidemiology
Background:
- Tularaemia is a zoonotic disease caused by the bacterium Francisella tularensis.
- Infections are typically caused by F tularensis subspecies tularensis (type A) in North America and F tularensis subspecies holarctica (type B) in Europe.
- Previous literature on tularaemia predominantly focused on US-based findings.
Purpose of the Study:
- To review and emphasize the specific and variable aspects of tularaemia in different European countries.
- To highlight novel data on tularaemia characteristics that have emerged in Europe over the past decade.
Main Methods:
- Literature review focusing on tularaemia in Europe.
- Synthesis of recent studies providing novel data on disease characteristics.
Main Results:
- Two distinct natural lifecycles of F tularensis have been identified in Europe.
- These lifecycles are associated with varying modes of transmission, clinical presentations, and public health burdens.
- Significant changes and novel data regarding tularaemia in Europe have emerged in the last decade.
Conclusions:
- Tularaemia exhibits significant variability across European countries.
- Understanding the distinct European F tularensis lifecycles is crucial for public health management.
- Further characterization of these lifecycles is needed to fully grasp their implications.
Related Concept Videos
Pulmonary Tuberculosis III
The first classification is based on the development of the disease, and it includes the following categories:
Pulmonary Tuberculosis IV
Several diagnostic approaches are used to detect TB. The conventional method is the Tuberculin Skin Test (TST), also known as the Mantoux test. However, this method has...
Endocarditis II: Clinical Features of Infective Endocarditis
Pulmonary Tuberculosis V
Latent tuberculosis infection occurs when TB bacteria are present in a person's body, but are not causing illness or symptoms. It is not contagious, and preventive treatment is crucial to avoid the...
Pulmonary Tuberculosis II
Here is a detailed explanation of its pathophysiology:
Transmission: The process begins when a person inhales droplet nuclei containing M. tuberculosis. These are typically released into the air when an individual with pulmonary or...
Pulmonary Tuberculosis I
Causative Organism
The primary infectious agent causing tuberculosis is Mycobacterium tuberculosis, a slow-growing, acid-fast, aerobic rod that exhibits sensitivity to heat and ultraviolet light. Instances of Mycobacterium bovis and Mycobacterium avium contributing to the development of TB infection are rare.
Mode of...

